Non-small Cell Lung Cancer
Conditions
Keywords
early-stage NSCLC, real-world evidences, patient survivals
Brief summary
The real-world study was designed to explore recurrence/metastases of the patients with non-small cell lung cancer as measured by patient survivals and the impact factors of patient survivals.
Detailed description
The trial was designed as a real-world observational study to recruit those patients with pathologically diagnosed early-phase non-small cell lung cancer (NSCLC) who were enrolled in the clinical form 2009 to 2017 and explore recurrence/metastases of the NSCLC patients as measured by patient survivals and the impact factors of patient survivals. The study data on patient demographic characteristics, tumor biological characteristics, and clinicla treatments were collected via a retrospectively review method for evaluation of patient survivals and the relevance of clinical characteristics of the patients and patient survivals.
Interventions
PROCEDURESurgeries
Surgical operations plus systematic lymphadenectomies
Sponsors
The First Affiliated Hospital of Guangzhou Medical University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
The patients who meet all the following inclusion criteria will be included in the study: * The patients who were operated with radical operations of the lung cancer; * The patients with clinical I-IIIA staging tumors; * The pathologically diagnosed NSCLC patients;
Exclusion criteria
\- Not be specified;
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Disease-free survival rates within the configured observation periods | 2009-2017 | Disease-free survival rates within 3-month, 6-month, 1-year, 2-year, and 3-year observation periods; |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Disease-free survival rates at the configured locations and observation periods | 2009-2017 | Disease-free survival rates at the metastasized lymph nodes, bone, and brain within 3-month, 6-month, 1-year, 2-year, and 3-year observation periods; |
Other
| Measure | Time frame | Description |
|---|---|---|
| Impact factors of disease-free survival rates | 2009-2017 | Impact factors of disease-free survival rates |
| Overall rates | 2009-2017 | Overall rates within 3 month-, 6 month-, 1 year-, 2 year-, and 3 year- observation periods |
| Rates of perioperative complications | 2009-2017 | Rates of perioperative complications |
Countries
China
Contacts
Primary ContactJianxing HE, MD
Backup ContactWenhua LIANG, Ph.D
Outcome results
None listed